Femasys Inc
NASDAQ:FEMY

Watchlist Manager
Femasys Inc Logo
Femasys Inc
NASDAQ:FEMY
Watchlist
Price: 1.14 USD 5.56% Market Closed
Market Cap: 31m USD

Femasys Inc
Investor Relations

Femasys, Inc. operates as a medical device company that focuses on women's healthcare. The company is headquartered in Suwanee, Georgia. The company went IPO on 2021-06-18. The firm is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The firm has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. FemaSeed is an artificial insemination infertility treatment. The firm also offers FemVue Saline-Air device for diagnosis of infertility and FemCerv Endocervical Sampler for diagnosis of cervical cancer. FemCerv is a sterile, single-use disposable endocervical curettage product that can be used to sample cervical cells and tissue, including in support of further testing following an abnormal Pap test to assess for any problems such as cancer, in a relatively pain-free office procedure.

Show more
Loading

Earnings Calls

No Earnings Calls Available

Management

Ms. Kathy Lee-Sepsick M.B.A.
Founder, President, CEO & Director
No Bio Available
Mr. Dov Elefant
Chief Financial Officer
No Bio Available
Mr. Daniel Scott Currie
COO, Senior VP & Secretary
No Bio Available
Ms. Mary An Merchant J.D., Ph.D.
Vice President of Counsel & Intellectual Property
No Bio Available
Ms. Sue Owens
Vice President of Sales
No Bio Available
Ms. Naomi Phaneuf
Vice President of Marketing
No Bio Available
Dr. Jeffrey Marcus M.D., M.S.
Chief Medical Advisor
No Bio Available
Ms. Christine Thomas
Senior VP of Regulatory & Clinical Affairs
No Bio Available
Dr. James H. Liu M.D.
Chief Medical Officer
No Bio Available
Mr. Richard Spector
Chief Commercial Officer
No Bio Available

Contacts

Address
GEORGIA
Suwanee
3950 Johns Creek Ct Ste 100
Contacts
+17705003910.0
www.femasys.com